Valuation A Complicated Game, Startups, Tech Cos Visualising Future: Thyrocare's Creator, Dr Velumani

Startups and tech companies across industries are being valued today at mountain-high valuations, with investors sprinkling the dry powder and founders aiming for volumes, scale and consolidation and not minding the losses. But the industry today is also not new to certain post-listing debacles of tech companies and a recent valuation turnaround of a health-tech company PharmEasy lowering its valuations by 90 per cent to fund its debt

Pharmeasy To Raise Funds Via Right Issue At 90% Discount: Report

On June 1, PharmEasy breached a key loan term set by Goldman Sachs as it failed to close a Rs 1,000 crore funding round. The firm is looking to repay Rs1,000cr loan

Pharmeasy Lays Off More Employees: Report

Pharmeasy a leading health tech startup has laid off more employees. The role affected are product, technology, quality analytics and others

Cashfree Payments Partners With PharmEasy To Automate Retail Network Transactions

Through this partnership, Cashfree Payments has also helped PharmEasy in tracking and processing bounced/failed payouts transactions

PharmEasy Planning To Raise $200 Million At Lower Valuation, Delays IPO

Betting on higher healthcare spends and growing use of online ordering, API Holdings last year filed a prospectus to raise 62.5 billion rupees ($782 million) in an IPO, hoping to list in 2022. The sources confirmed that plan is now delayed. One concern among investors before the market debut is mounting losses of the digital pharmacy, the sources said

Pharmeasy To Acquire Thyrocare In Rs 4,546 Crore-Deal

Shares of Thyrocare closed 6.23 per cent up at Rs 1,448.05 apiece on BSE on Friday.

E-pharmacy: Caught In A Logjam

Delay in formalisation of draft rules is causing confusion and panic among stakeholders of an otherwise booming e-pharmacy business

India Asks States To Halt Online Drug Sales

India is yet to finalise regulations for online drug sales, or e-pharmacies, but the growth of several online sellers such as Medlife, Netmeds, Temasek-backed PharmEasy and Sequoia Capital-backed 1mg has threatened traditional drug-store businesses.

Performics.Convonix Bags Media Mandate For PharmEasy

The mandate involves all of the paid media and was won as part of a highly competitive multi-agency pitch

PharmEasy Among Most Trusted Brands 2016

The company has been rated as the most admired brand in the healthcare category in the country thanks to its business model that makes healthcare easily available, accessible and affordable for all

Bitter Pill | E-Pharmacies: Don't Open Yet Another Big Avenue For Counterfeiters Now